Certara Executive and Leadership Team

Jon Resnick, the Chief Executive Officer at Certara, directs the overarching corporate strategy and long-term vision for the organization. Resnick oversees the integration of biosimulation technologies into the global drug development lifecycle, ensuring that scientific consulting services remain at the forefront of industry innovation. By aligning internal resources with the needs of pharmaceutical partners, the Chief Executive Officer drives operational excellence across all preclinical and clinical trial initiatives. This leadership role involves constant engagement with the Board to maintain market leadership in model-informed drug development. Jon Resnick prioritizes the expansion of AI-driven platforms to enhance regulatory submission success rates. Through rigorous oversight of organizational performance, the Chief Executive Officer secures sustainable growth and maintains the company's reputation as a critical partner in the life sciences sector, ultimately delivering value to stakeholders while advancing patient health outcomes worldwide.

Faiz Mohammed, the Interim Chief Financial Officer. at Certara, manages the financial health and fiscal strategy of the organization. Mohammed oversees financial planning, reporting, and capital allocation to ensure the company maintains the resources necessary for continued investment in biosimulation and AI technologies. By monitoring key performance indicators and operational costs, the Interim Chief Financial Officer. provides the executive team with the data required to make informed strategic decisions. This leadership role involves maintaining rigorous financial controls and ensuring compliance with regulatory standards across all global operations. Faiz Mohammed collaborates with the Board to communicate financial performance and long-term value creation to investors. Through the optimization of financial processes, the Interim Chief Financial Officer. supports the company's growth objectives and ensures the stability of the business model. Mohammed maintains a focus on fiscal discipline, enabling the organization to pursue its mission of transforming drug development through scientific innovation.

Adrian McKemey, the President, Certara Drug Development Solutions at Certara, leads the delivery of scientific consulting services across the drug development lifecycle. McKemey oversees the teams providing expertise in preclinical modeling, clinical trials, and regulatory submissions. By ensuring that clients receive actionable insights through model-informed drug development, the President, Certara Drug Development Solutions drives the successful execution of complex development programs. This leadership role involves managing client relationships and ensuring that service delivery meets the highest standards of scientific rigor. Adrian McKemey coordinates with other business units to integrate software and consulting capabilities, providing a comprehensive solution for pharmaceutical partners. Through the expansion of service offerings in key global regions, the President, Certara Drug Development Solutions enhances the company's impact on clinical outcomes. McKemey focuses on operational efficiency and service quality, ensuring that the organization remains a trusted partner for companies navigating the challenges of modern drug development.

Leif Pedersen, the President & Chief Commercial Officer at Certara, directs the global commercial strategy and revenue growth initiatives. Pedersen oversees the sales and business development teams responsible for expanding the adoption of biosimulation software and consulting services. By identifying new market opportunities and managing key account relationships, the President & Chief Commercial Officer ensures that the company's solutions reach a broad base of pharmaceutical and biotechnology clients. This leadership role involves aligning commercial efforts with the company's product roadmap to maximize market penetration. Leif Pedersen drives the execution of go-to-market strategies across international territories, ensuring that the organization meets its revenue targets. Through the continuous refinement of the sales process, the President & Chief Commercial Officer supports the company's mission to optimize drug development outcomes. Pedersen maintains a focus on customer success, ensuring that the commercial organization delivers value and fosters long-term partnerships with clients worldwide.

Martin Snyder, the President, Certara Data Sciences at Certara, leads the specialized data science division focused on advanced analytics and computational modeling. Snyder oversees the development of data-driven methodologies that support drug discovery and clinical trial optimization. By leveraging large-scale datasets and machine learning, the President, Certara Data Sciences ensures that the company provides cutting-edge analytical capabilities to its partners. This leadership role involves managing the integration of data science into the broader drug development lifecycle, enhancing the predictive power of the company's platforms. Martin Snyder collaborates with technology and consulting teams to solve complex scientific challenges and improve the efficiency of regulatory submissions. Through the application of rigorous data standards, the President, Certara Data Sciences drives innovation in the field of biosimulation. Snyder focuses on expanding the division's analytical reach, ensuring that the organization remains at the forefront of data-driven drug development and clinical research.

Sheila Rocchio, the Chief Marketing Officer at Certara, architects the global brand strategy and market positioning for the company's suite of biosimulation software. Rocchio manages the communication of complex scientific value propositions to diverse stakeholders within the pharmaceutical and biotechnology industries. Overseeing demand generation and product marketing, the Chief Marketing Officer ensures that the unique benefits of model-informed drug development reach key decision-makers across North American and European markets. This leadership role requires close collaboration with product teams to translate technical advancements into compelling market narratives. Sheila Rocchio drives the digital engagement strategy, utilizing data-driven insights to optimize lead conversion and brand awareness. By aligning marketing initiatives with the broader corporate mission, the Chief Marketing Officer strengthens the company's competitive advantage, ensuring that the organization remains the preferred partner for drug developers seeking to improve clinical trial efficiency and regulatory success.

Chris Bouton, the Chief Technology Officer at Certara, leads the development and deployment of AI-driven platforms and software solutions. Bouton oversees the engineering teams responsible for building scalable biosimulation tools that predict drug behavior throughout the development lifecycle. By integrating advanced computational models into the company's core offerings, the Chief Technology Officer ensures that clients receive high-fidelity insights for preclinical and clinical decision-making. This leadership role involves managing the technical roadmap and fostering innovation in data science applications. Chris Bouton collaborates with the executive team to align technological capabilities with evolving regulatory requirements and market demands. Through the continuous improvement of software architecture, the Chief Technology Officer enhances the speed and accuracy of drug development processes. Bouton maintains a focus on technical excellence, ensuring that the company's digital infrastructure supports complex scientific workflows and provides a robust foundation for future growth in the global life sciences market.

Rona Anhalt, the Chief Human Resources Officer at Certara, directs the global talent strategy and organizational development initiatives. Anhalt oversees recruitment, employee engagement, and performance management to ensure the company attracts and retains top-tier scientific and technical talent. By fostering a culture of innovation and collaboration, the Chief Human Resources Officer supports the workforce in delivering high-quality consulting services and software solutions. This leadership role involves designing programs that promote professional growth and align individual contributions with the company's strategic objectives. Rona Anhalt manages the integration of human capital across international operations, ensuring consistent standards of excellence and operational efficiency. Through the implementation of robust HR policies, the Chief Human Resources Officer drives organizational health and supports the company's mission to accelerate drug development. Anhalt ensures that the internal environment remains conducive to the high-level scientific work required to maintain the company's market-leading position in the pharmaceutical services industry.